Neurostar TMS Therapy
NeuroStar TMS Therapy is
the first and only non-systemic and non-invasive outpatient depression treatment
cleared by the US Food and Drug Administration (FDA) for patients who have not
benefited from prior antidepressant treatment. NeuroStar TMS Therapy uses highly
focused, pulsed magnetic fields to stimulate function in targeted brain
regions.
NeuroStar TMS Therapy is:
the first and only non-systemic and non-invasive outpatient depression treatment
cleared by the US Food and Drug Administration (FDA) for patients who have not
benefited from prior antidepressant treatment. NeuroStar TMS Therapy uses highly
focused, pulsed magnetic fields to stimulate function in targeted brain
regions.
NeuroStar TMS Therapy is:
- Non-invasive, meaning that it does not involve surgery. It does not require
any anesthesia or sedation, as the patient remains awake and alert during the
treatment. - Non-systemic, meaning that it is not taken by mouth and does not circulate
in the bloodstream throughout the body.